Mammary Cell News Volume 15.10 | Mar 16 2023

    0
    61








    2023-03-16 | MCN 15.10


    Mammary Cell News by STEMCELL Technologies
    Vol. 15.10 – 16 March, 2023
    TOP STORY

    Preneoplastic Stromal Cells Promote BRCA1-Mediated Breast Tumorigenesis

    Using single-cell RNA sequencing analysis of human preneoplastic BRCA1+/mut and noncarrier breast tissues, researchers showed distinct changes in epithelial homeostasis including increased proliferation and expansion of basal-luminal intermediate progenitor cells.
    [Nature Genetics]

    Abstract
    Resources for Your T Cell Therapy Research
    PUBLICATIONSRanked by the impact factor of the journal

    Age-Associated Microenvironmental Changes Highlight the Role of PDGF-C in ER+ Breast Cancer Metastatic Relapse

    Investigators used syngeneic ER+ mouse models in which disseminated tumor cells displayed a dormant phenotype in young mice but accelerated metastatic outgrowth in an aged or fibrotic microenvironment.
    [Nature Cancer]

    Full ArticlePress Release

    Intercellular HIF1a Reprogams Mammary Progenitors and Myeloid Immune Evasion to Drive High-Risk Breast Lesions

    The authors showed that invasive breast cancer cells exposed to hypoxia released small extracellular vesicles that disrupted the differentiation of normal mammary epithelia, expanded stem and luminal progenitor cells, and induced atypical ductal hyperplasia and intraepithelial neoplasia.
    [Journal Of Clinical Investigation]

    AbstractGraphical Abstract

    A Lamb1Dendra2 Mouse Model Identifies Basement-Membrane-Producing Origins and Dynamics in PyMT Breast Tumors

    To study the origin and dynamics of the basement membrane (BM), scientists developed and imaged a laminin beta1-Dendra2 mouse model. They showed that the turnover of laminin beta1 was faster in the BMs that surrounded the tumor lobes than in the BMs that surrounded the healthy epithelium.
    [Developmental Cell]

    Full ArticleGraphical Abstract

    LncRNA XIST Regulates Breast Cancer Stem Cells by Activating Proinflammatory IL-6/STAT3 Signaling

    Investigators identified X-inactive specific transcript (XIST) as a key regulator of breast cancer stem cells, which exhibited aldehyde dehydrogenase positive epithelial-and CD24loCD44hi mesenchymal-like phenotypes.
    [Oncogene]

    Full Article

    MUC16 Promotes Triple-Negative Breast Cancer Lung Metastasis by Modulating RNA-Binding Protein ELAVL1/HUR

    The clinical significance of mucin 16 (MUC16) and ELAVL1 or Hu antigen R was examined using breast cancer TCGA data. Microarray was performed on MUC16 knockdown and scramble TNBC cells, and MUC16-associated genes were identified using RNA immunoprecipitation and metastatic cDNA array.
    [Breast Cancer Research]

    Full Article

    Tumor-Expressed Factor VII Associates with Survival and Regulates Tumor Progression in Breast Cancer

    In breast cancer cell lines, tumor-expressed FVII drove changes reminiscent of epithelial-to-mesenchymal transition, tumor cell invasion, and expression of the pro-metastatic genes SNAI2 and SOX9.
    [Blood Advances]

    Abstract

    Paracrine Secretion of IL8 by Breast Cancer Stem Cells Promotes Therapeutic Resistance and Metastasis of the Bulk Tumor Cells

    Co-culture systems in vitro and co-implantation systems in vivo were designed to characterize the interactions between breast cancer stem cells and bulk cancer cells.
    [Cell Communication and Signaling]

    Full Article

    Overexpression of Tripartite Motif-Containing 47 (TRIM47) Confers Sensitivity to PARP Inhibition via Ubiquitylation of BRCA1 in Triple Negative Breast Cancer Cells

    Researchers showed that overexpression of TRIM47 correlated with progression and poor prognosis in TNBC. They demonstrated that TRIM47 directly interacted with breast cancer susceptibility gene 1 (BRCA1) and induced ubiquitin-ligase-mediated proteasome turnover of BRCA1.
    [Oncogenesis]

    Full Article

    Fluorouracil Exacerbates Alpha-Crystallin B Chain—Mediated Cell Migration in Triple-Negative Breast Cancer Cell Lines

    Scientists evaluated the effect of fluorouracil, a typical chemotherapy for the treatment of TNBC, on cell motility by utilizing a cell line with high αB-crystallin expression.
    [Scientific Reports]

    Full Article
    Enjoy your weekend. Your cells will too. Reduce medium acidosis with mTeSR™ Plus.
    REVIEWS

    Deciphering Breast Cancer: From Biology to the Clinic

    Multi-dimensional integration of high-resolution single-cell and spatial technologies has highlighted the importance of the entire breast cancer ecosystem and the presence of distinct cellular “neighborhoods.”
    [Cell]

    Abstract

    RET Signaling in Breast Cancer Therapeutic Resistance and Metastasis

    The authors assess the status of research on RET in breast cancer and evaluate the therapeutic potential of RET-selective kinase inhibitors across major breast cancer subtypes.
    [Breast Cancer Research]

    Full Article
    INDUSTRY AND POLICY NEWS

    Agendia Announces First Patient Enrolled in PROOFS Registry Trial to Determine Optimal Treatment and Ability to Forgo Chemotherapy for Premenopausal Women with Early HR+ Breast Cancer

    Agendia, Inc. announced the first patient has been enrolled in the PROOFS Registry trial. The study aims to determine whether premenopausal women with early HR+ breast cancer can avoid chemotherapy, and maintain strong outcomes by opting for temporary ovarian function suppression with endocrine therapy.
    [Agendia, Inc.]

    Press Release
    FEATURED EVENT

    The Resistant Tumor Microenvironment

    May 7 – 10, 2023
    Vancouver, British Columbia, Canada

    > See All Events

    JOB OPPORTUNITIES

    Associate Research Scientists – Cancer Genetics

    Columbia University – New York City, New York, United States

    Postdoctoral Research Fellow – Medical Oncology

    Dana-Farber Cancer Institute – Boston, Massachusetts, United States

    Postdoctoral Fellowship – Breast Cancer

    Harvard Medical School – Boston, Massachusetts, United States

    Postdoctoral Fellow – Cancer Imaging & Drug Delivery

    University of Oklahoma Health Sciences Center – Oklahoma City, Oklahoma, United States

    Assistant Professor – Breast Cancer Biology

    University of Alberta – Edmonton, Alberta, Canada

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2
    Mammary Cell News Twitter